NEXTURNBIOSCIENCE Co., Ltd. (KOSDAQ:089140)

NEXTURNBIOSCIENCE Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	39,261	33,999	51,872	65,856	200,064	124,142
Market Cap Growth	-22.83%	-34.46%	-21.23%	-67.08%	61.16%	344.80%
Enterprise Value	80,697	84,865	86,701	126,455	191,439	117,721
Last Close Price	3060.00	2795.00	5520.00	8475.00	31200.00	19833.33
PE Ratio	-	-	5.36	-	-	-
PS Ratio	1.24	1.08	1.26	2.81	11.79	12.82
PB Ratio	0.29	0.25	0.38	0.61	2.16	1.28
P/TBV Ratio	0.29	0.25	0.38	0.63	2.16	1.29
P/FCF Ratio	-	-	-	-	62.58	-
P/OCF Ratio	-	-	-	-	54.60	526.16
EV/Sales Ratio	2.55	2.68	2.10	5.39	11.28	12.15
EV/EBITDA Ratio	-	149.66	118.47	-	-	-
EV/FCF Ratio	-39.70	-	-	-	59.88	-
Debt / Equity Ratio	0.60	0.60	0.56	0.70	0.31	0
Debt / EBITDA Ratio	83.23	143.23	104.90	-	-	-
Debt / FCF Ratio	-	-	-	-	8.88	-
Asset Turnover	0.13	0.13	0.19	0.14	0.14	-
Inventory Turnover	2.76	3.39	4.84	2.93	1.98	-
Quick Ratio	2.37	1.77	0.41	1.84	1.05	27.58
Current Ratio	3.01	2.33	0.50	2.23	1.18	32.29
Return on Equity (ROE)	-10.91%	-9.47%	7.53%	-4.85%	-4.68%	-
Return on Assets (ROA)	-0.28%	-0.38%	-0.36%	-1.67%	-1.25%	-
Return on Capital (ROIC)	-0.30%	-0.42%	-0.40%	-1.86%	-1.37%	-
Earnings Yield	-38.78%	-38.25%	18.66%	-7.12%	-2.22%	-1.96%
FCF Yield	-5.18%	-5.26%	-5.88%	-2.14%	1.60%	-0.79%
Buyback Yield / Dilution	-10.97%	-8.38%	-48.59%	-5.86%	-	-
Total Shareholder Return	-	-8.38%	-48.59%	-5.86%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.